nach oben

Acta Diabetologica

Erschienen in:

08.12.2016 | Original Article

Costs of diabetes medication among male former elite athletes in later life

verfasst von: M. K. Laine, R. Kujala, J. G. Eriksson, H. Kautiainen, S. Sarna, U. M. Kujala

Erschienen in: Acta Diabetologica | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

Regular physical activity plays a major role, in both prevention and treatment of type 2 diabetes. Less is known whether vigorous physical activity during young adulthood is associated with costs of diabetes medication in later life. The aim of this study is to evaluate this question.

Methods

The study population consisted of 1314 former elite-class athletes and 860 matched controls. The former athletes were divided into three groups based on their active career sport: endurance, mixed and power sports. Information on purchases of diabetes medication between 1995 and 2009 was obtained from the drug purchase register of the Finnish Social Insurance Institution.

Results

The total cost of diabetes medication per person year was significantly lower among the former endurance (mean 81 € [95% CI 33–151 €]) and mixed group athletes (mean 272 € [95% CI 181–388 €]) compared with the controls (mean 376 € [95% CI 284–485 €]), (p < 0.001 and p = 0.045, respectively). Of the former endurance athletes, 0.4% used insulin, while 5.2% of the controls used insulin (p = 0.018).

Conclusions

A career as former endurance, sprint, jumper or team game athlete seems to reduce the costs of diabetes medication in later life.

International Diabetes Federation (2015) IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation. http://www.diabetesatlas.org. Accessed 27 Sept 2016

Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152CrossRefPubMed

Lynch J, Helmrich SP, Lakka TA et al (1996) Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156:1307–1314CrossRefPubMed

Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20:537–544CrossRefPubMed

Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRefPubMed

Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed

Espeland MA, Glick HA, Bertoni A, Look AHEAD Research Group et al (2014) Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care 37:2548–2556CrossRefPubMedPubMedCentral

Paffenbarger RS Jr, Jung DL, Leung RW, Hyde RT (1991) Physical activity and hypertension: an epidemiological view. Ann Med 23:319–327CrossRefPubMed

Laine MK, Eriksson JG, Kujala UM et al (2014) A former career as a male elite athlete-does it protect against type 2 diabetes in later life? Diabetologia 57:270–274CrossRefPubMed

10.

Umpierre D, Ribeiro PAB, Kramer CK et al (2011) Physical activity advice only or structured exercise training and association with HbA_1c levels in type 2 diabetes. JAMA 305:1790–1799CrossRefPubMed

11.

McGinley SK, Armstrong MJ, Boule NG, Sigal RJ (2015) Effects of exercise training using resistance bands on glycaemic control and strenght in type 2 diabetes mellitus: a meta-analysis of randomised controlled trials. Acta Diabetol 52:221–230CrossRefPubMed

12.

Liubaoerjijin Y, Terada T, Fletcher K, Boule NG (2016) Effect of aerobic intensity on glycemic control in type 2 diabetes: a meta-analysis of head-to-head randomized trials. Acta Diabetol 53:769–781CrossRefPubMed

13.

Chacko E (2016) Timing, intensity and frequency of exercise for glucose control. Acta Diabetol. doi:10.1007/s00592-016-0886-5 PubMed

14.

Boule NG, Liubaoerjijin Y, Terada T (2016) Reply to Elsamma Chacko: “ timing, intensity and frequency of exercise for glucose control”. Acta Diabetol. doi:10.1007/s00592-016-0887-4

15.

Balducci S, Vulpiani MC, Pugliese L et al (2014) Effect of supervised exercise training on musculoskeletal symptoms and function in patients with type 2 diabetes: the Italian Diabetes Exercise Study (IDES). Acta Diabetol 51:647–654CrossRefPubMed

16.

Sarna S, Sahi T, Koskenvuo M, Kaprio J (1993) Increased life expectancy of world class male athletes. Med Sci Sports Exerc 25:237–244CrossRefPubMed

17.

Åstrand P, Rodahl K (1986) Physiological bases of exercise. In: Textbook of work physiology. McGraw Hill, New York, pp 412–415

18.

WHO (2003) Introduction to drug utilization research. apps.who.int/medicinedocs/en/d/Js4876e/. Accessed 27 Sept 2016

19.

Consumer price index (e-publication). ISSN = 1799–0254. Helsinki: Statistics Finland. Available at: http://www.stat.fi/til/khi/men_en.html. Accessed 27 Sept 2016

20.

Classification of Occupations (2010). Available at: http://stat.fi/meta/luokitukset/ammatti/001-2010/index_en.html. Accessed 27 Sept 2016

21.

Kujala UM, Sarna S, Kaprio J (2003) Use of medications and dietary supplements in later years among male former top-level athletes. Arch Intern Med 163:1064–1068CrossRefPubMed

22.

Sarna S, Kaprio J, Kujala UM, Koskenvuo M (1997) Health status of former elite athletes. The Finnish experience. Aging (Milano) 9:35–41

23.

Alouki K, Delisle H, Bermudez-Tamayo C, Johri M (2016) Lifestyle interventions to prevent type 2 diabetes: a systematic review of economic evaluation studies. J Diabetes Res. doi:10.1155/2016/2159890 PubMedPubMedCentral

24.

Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ (2004) Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 26:304–321CrossRefPubMed

25.

Diabetes Prevention Program Research Group (2012) The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 35:723–730CrossRef

26.

Liu X, Li C, Gong H et al (2013) An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. BMC Public Health. doi:10.1186/1471-2458-13-729

27.

Saha S, Carlsson KS, Gerdtham UG et al (2013) Are lifestyle interventions in primary care cost-effective?—An analysis based on a Markov model, differences-in-differences approach and the Swedish Bjorknas study. PLoS ONE. doi:10.1371/journal.pone.0080672

28.

Bertram MY, Lim SS, Barendregt JJ, Vos T (2010) Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 53:875–881CrossRefPubMed

29.

Balducci S, Sacchetti M, Haxhi J et al (2014) Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. doi:10.1002/dmrr.2514

30.

Kujala UM (2011) Physical activity, genes, and lifetime predisposition to chronic disease. European review of aging and physical activity: 31–36

31.

Colberg SR, Sigal RJ, Fernhall B et al (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33:2692–2696CrossRefPubMedPubMedCentral

32.

Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746–2753CrossRefPubMed

33.

Andersen P, Saltin B (1985) Maximal perfusion of skeletal muscle in man. J Physiol 366:233–249CrossRefPubMedPubMedCentral

34.

Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017CrossRefPubMed

35.

Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W et al (2004) Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 53:1233–1242CrossRefPubMed

36.

Costill DL, Fink WJ, Pollock ML (1976) Muscle fiber composition and enzyme activities of elite distance runners. Med Sci Sports 8:96–100PubMed

37.

Lundsgaard AM, Kiens B (2014) Gender differences in skeletal muscle substrate metabolism—molecular mechanisms and insulin sensitivity. Front Endocrinol. doi:10.3389/fendo.2014.00195

38.

Phielix E, Meex R, Ouwens DM et al (2012) High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance. Diabetes 61:2472–2478CrossRefPubMedPubMedCentral

39.

Aadahl M, Kjaer M, Jorgensen T (2007) Associations between overall physical activity level and cardiovascular risk factors in an adult population. Eur J Epidemiol 22:369–378CrossRefPubMed

40.

Philipsen A, Hansen AL, Jorgensen ME et al (2015) Associations of objectively measured physical activity and abdominal fat distribution. Med Sci Sports Exerc 47:983–989CrossRefPubMed

41.

Shojaee-Moradie F, Baynes KC, Pentecost C et al (2007) Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50:404–413CrossRefPubMed

42.

Johnson NA, Sachinwalla T, Walton DW et al (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:1105–1112CrossRefPubMed

43.

van der Heijden GJ, Wang ZJ, Chu ZD et al (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity 18:384–390CrossRefPubMed

44.

Kujala UM, Jokelainen J, Oksa H et al (2011) Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes. BMJ Open. doi:10.1136/bmjopen-2011-000292 PubMedPubMedCentral

Titel: Costs of diabetes medication among male former elite athletes in later life
verfasst von: M. K. Laine
R. Kujala
J. G. Eriksson
H. Kautiainen
S. Sarna
U. M. Kujala
Publikationsdatum: 08.12.2016
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 4/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-016-0947-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Costs of diabetes medication among male former elite athletes in later life

Abstract

Aims

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Cardiovascular complications of type 1 diabetes: update on the renal link

Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus

Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials

Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge

Examining trends in prediabetes and its relationship with the metabolic syndrome in US adolescents, 1999–2014

Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin